Tag: Bladder
Search News
NHS changes guidelines for bladder cancer patients following new clinical trial results
12th February 2026
Thousands of people with advanced bladder cancer across the UK will now receive three rather than six chemotherapy cycles after Queen Mary University of London-led research led to a change to NHS treatment guidelines. For patients, this means fewer toxic side effects and a better quality of life during treatment.
Read more
Breakthrough life-extending treatment for advanced bladder cancer available on NHS
21st August 2025
The new combination treatment offers hope to thousands of people living with advanced urothelial cancer. The clinical trials, led by Professor Tom Powles at Barts Cancer Institute, Queen Mary University of London, showed that overall survival rates were almost twice as long with this new treatment compared to the current standard treatment.
Read more
BCI part of new UK-wide cancer immunotherapy initiative
7th October 2024
Researchers from Barts Cancer Institute, Queen Mary University of London are part of a nationwide team of universities, hospitals and industry collaborating on a new platform to understand immunotherapy response and side effects in cancer.
Read more
Groundbreaking trials reveal improved survival for two hard-to-treat cancers
16th September 2024
Prof Tom Powles and Prof Peter Schmid announced practice-changing results at ESMO 2024
Read more
International Clinical Trials Day – how Barts clinical trials are changing cancer care
20th May 2024
To mark International Clinical Trials Day 2024, we’re spotlighting some of our clinical trial work and how it is helping to transform the lives of people with cancer.
Read more
Thomas Powles named in TIME’s list of the 100 most influential people in global health this year
2nd May 2024
Professor Powles has been recognised for his transformative clinical work delivering a life-extending treatment for severe bladder cancer.
Read more